LIPOROSA 20 mg/10 mg, hard capsule 90 capsules
Active ingredients: Rosuvastatin, Rosuvastatin zinc, Ezetimibe
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule90 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LIPOROSA 20 mg/10 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) formée(s) à froid polyamide aluminium PVC-Aluminium de 90 gélule(s)
- Marketing authorisation holder
- BB FARMA (ITALIE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Jul 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66646146CIP74900555CIP133400949005550Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ROSUVASTATINE ZINCIQUEgélule | — | SA |
| ROSUVASTATINEgélule | 20 mg · une gélule | FT |
| ÉZÉTIMIBEgélule | 10 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.